The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
AMCI Acquisition - Greenwich, Conn., 20 million shares, priced at $10, managed by Jefferies/UBS Investment Bank. Proposed Nasdaq symbol AMCIU. Business: Blank check company formed by coal industry veteran Hans Mende.
Alzheon - Framingham, Mass., 6 million shares, priced $4-$6, managed by ThinkEquity/H.C. Wainwright. Proposed Nasdaq symbol ALZH. Business: Phase 3 biotech developing small molecule therapies for Alzheimer's disease.
Centrexion Therapeutics - Boston, 5 million shares, priced $14-$16, managed by BofA Merrill Lynch/Leerink Partners. Proposed Nasdaq symbol CNTX. Business: Developing non-opioid therapies for chronic pain.
FinTech Acquisition III - Philadelphia, 27.5 million shares, priced at $10, managed by Cantor Fitzgerald. Proposed Nasdaq symbol FTACU. Business: Blank check formed by management of The Bancorp to acquire a financial technology.
Qualtrics International - Provo, Utah, 20 million shares, priced $18-$21, managed by Morgan Stanley/Goldman Sachs. Proposed Nasdaq symbol XM. Business: Provides software used to analyze and improve user experience.
Uranium Trading Corp.- El Segundo. Calif., 4.5 million shares, priced $10-$12, managed by B. Riley FBR. Proposed NYSE symbol UTC. Business: Newly-formed vehicle investing in the civil uranium market.
Vapotherm - Exeter, N.H., 4 million shares, priced $14-$16, managed by BofA Merrill Lynch/William Blair. Proposed NYSE VAPO. Business: Provides noninvasive breathing aids to treat respiratory distress.
Weidai - China, 4.5 million shares, priced $9-$11, managed by Morgan Stanley/Citi. Proposed NYSE symbol WEI. Business: Provides an auto-secured loan platform for small businesses in China.